About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Chicago | 17,839 Studies Near You

Clinical TrialsChicago

Clinical Trials in Chicago

Discover 17,839 clinical trials near Chicago, Illinois. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 2081-2100 of 17,839 trials

CompletedA Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological MalignanciesThe Phase 1 portion of the study will evaluate the pharmacokinetic profile and safety of ABT-263 with the objective of defining the dose limiting toxicity and maximum tolerated…NCT00445198·Peoria, Arizona and 17 others CompletedLubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient RehabilitationPatients requiring opioids for post-operative pain control following elective orthopedic procedures which has resulted in constipation symptoms, and who are in inpatient…NCT00662363·Chicago, Illinois

Find Trials by Condition in Chicago

Breast Cancerin Chicago Lung Cancerin Chicago Prostate Cancerin Chicago Colorectal Cancerin Chicago Melanomain Chicago Leukemiain Chicago Lymphomain Chicago Pancreatic Cancerin Chicago Ovarian Cancerin Chicago Brain Cancerin Chicago Diabetes

Data from ClinicalTrials.govTerms

CompletedStudy of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior TherapyThe purpose of the study is to evaluate the objective tumor response rate of amrubicin when administered as second-line therapy to ED-SCLC patients who have refractory or…NCT00375193·Phoenix, Arizona and 45 others

Active not recruitingNivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaThis phase I trial studies the side effects of nivolumab, BMS-986205, and standard radiation therapy with or without temozolomide in treating patients with new diagnosed…NCT04047706·Chicago, Illinois

CompletedGRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host DiseaseThe purpose of this study is to evaluate itacitinib or placebo in combination with corticosteroids as first-line treatment of participants with Grade II to IV acute…NCT03139604·La Jolla, California and 128 others

CompletedBispectral Index and End-Tidal Anesthetic Gas Concentration in Pediatric PatientsThe purpose of this study is to investigate the relationship between BIS™ values including EEG profile and anesthetic agents in the pediatric populationNCT04810481·Aurora, Colorado and 7 others

CompletedAssess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver FailureThe primary objective of the study is to evaluate safety and efficacy of ELAD® with respect to overall survival (OS) of subjects with a clinical diagnosis of alcohol-induced liver…NCT01471028·Phoenix, Arizona and 44 others

TerminatedSafety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal CancerThis 2-part, Phase 1/2 study will test investigational cancer drugs known as CRS-207, epacadostat (IDO), and pembrolizumab (pembro).NCT02575807·Scottsdale, Arizona and 11 others

CompletedA Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple MyelomaThe purpose of the study is to characterize safety of JNJ-68284528 and establish the recommended Phase 2 dose (RP2D) (Phase 1b) and to evaluate the efficacy of JNJ-68284528 (Phase…NCT03548207·Phoenix, Arizona and 20 others

CompletedBlepharospasm ToolsThe aim of this study is to develop new rating scales to help diagnose and measure the severity of blepharospasm.NCT02780336·Aurora, Colorado and 10 others

CompletedHuman Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing SpondylitisThe objective of this study was to evaluate the safety and efficacy of adalimumab 40 mg given every other week (eow) in subjects with active ankylosing spondylitis (AS) who have…NCT00085644·Birmingham, Alabama and 21 others

CompletedSafety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and AdolescentsIntegrase is 1 of 3 HIV (Human Immunodeficiency Virus)-1 enzymes required for viral replication. Raltegravir is a drug that prevents integrase from working properly.NCT00485264·Alhambra, California and 41 others

TerminatedStudy To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19This is a single-center, randomized double blind placebo controlled trial to evaluate the efficacy and safety of novel PAI-1 inhibitor (TM5614) for high-risk patients hospitalized…NCT04634799·Chicago, Illinois

CompletedEfficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic AgentThis trial is conducted in the United States of America (USA).NCT01511198·Vestavia Hills, Alabama and 38 others

Active not recruitingA Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated DiseasesThe purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with EBV-associated diseases.NCT04554914·Los Angeles, California and 39 others

CompletedA Phase 2b Study of Icosabutate in Fatty Liver DiseaseA Phase 2b study to evaluate the efficacy of different doses of NST-4016 on the resolution of NASH without worsening of fibrosisNCT04052516·Birmingham, Alabama and 38 others

Active not recruitingComparing Meniscal Repair Biologic Augmentation: Marrow Venting Procedure Versus PRP (MVP Trial)There are no current or past RCT comparing biologic augments for meniscal repair.NCT04775004·Gainesville, Florida and 2 others

CompletedCommunity Intervention Trial for Youth (CITY) StudyThe purpose of this study is to test whether a multi-component, community-level, HIV-prevention intervention is more effective than existing HIV prevention activities in reducing…NCT00164580·Birmingham, Alabama and 7 others

CompletedPostprandial Glycemia in Apple ProductsThe primary objective of the study is to compare the effects of a whole apple, apple juice alone, and apple juice with pomace on 2 hr glycemic response as measured by maximal…NCT03846986·Chicago, Illinois

CompletedCLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell MalignanciesCLBR001 + SWI019 is an combination investigational immunotherapy being evaluated as a potential treatment for patients diagnosed with B cell malignancies who are refractory or…NCT04450069·Duarte, California and 7 others

PreviousPage 105 of 892Next

in Chicago

Heart Diseasein Chicago